Free Trial

Renaissance Technologies LLC Has $825,000 Stock Holdings in Cronos Group Inc. (NASDAQ:CRON)

Cronos Group logo with Medical background

Renaissance Technologies LLC reduced its stake in shares of Cronos Group Inc. (NASDAQ:CRON - Free Report) by 38.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 408,341 shares of the company's stock after selling 257,608 shares during the quarter. Renaissance Technologies LLC owned 0.11% of Cronos Group worth $825,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also made changes to their positions in CRON. Barclays PLC acquired a new position in Cronos Group during the third quarter valued at approximately $97,000. Janney Montgomery Scott LLC boosted its holdings in shares of Cronos Group by 72.2% during the fourth quarter. Janney Montgomery Scott LLC now owns 380,575 shares of the company's stock valued at $769,000 after acquiring an additional 159,575 shares during the period. Jones Financial Companies Lllp grew its holdings in Cronos Group by 64.5% in the 4th quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company's stock worth $34,000 after buying an additional 6,520 shares in the last quarter. SBI Securities Co. Ltd. bought a new stake in shares of Cronos Group during the 4th quarter worth about $30,000. Finally, Arrowstreet Capital Limited Partnership acquired a new stake in shares of Cronos Group in the fourth quarter valued at $76,000. Hedge funds and other institutional investors own 8.71% of the company's stock.

Cronos Group Price Performance

NASDAQ CRON remained flat at $1.85 on Wednesday. 1,463,018 shares of the company's stock traded hands, compared to its average volume of 1,342,531. Cronos Group Inc. has a 12-month low of $1.60 and a 12-month high of $3.14. The business's 50-day moving average price is $1.82 and its 200-day moving average price is $1.95. The company has a market cap of $713.00 million, a P/E ratio of -14.23, a price-to-earnings-growth ratio of 1.74 and a beta of 1.06.

Cronos Group Profile

(Free Report)

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.

See Also

Institutional Ownership by Quarter for Cronos Group (NASDAQ:CRON)

Should You Invest $1,000 in Cronos Group Right Now?

Before you consider Cronos Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.

While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines